DICER1 Mutations Exhibit a Distinctive Immune Characteristics With Enhanced Immune Checkpoint Inhibitor Efficacy in Uterine Corpus Endometrial Carcinoma
Clin Oncol (R Coll Radiol). 2025 May 30:44:103883.
doi: 10.1016/j.clon.2025.103883.
Online ahead of print.
1 Department of Gynaecology, The Fourth Affiliated Hospital of China Medical University, Liaoning Province, 110000, People's Republic of China.
2 The State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co.,Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, People's Republic of China.
3 Oncology Department, People's Hospital of Liaoning Province, People's Hospital of China Medical University, Liaoning Province, 110000, People's Republic of China.